Registration on a Public Database If you are planning to conduct a randomised controlled trial or a study designed to assess the efficacy of a healthcare intervention, it must be registered with an International Committee of Medical Journal Editors' (ICMJE) approved scheme. The ICMJE’s aim is to stop selective reporting of positive trials and allow the many stakeholders in clinical research to explore a full range of clinical evidence. If your study has not been submitted to an approved registry before enrollment of the first participant, you may not be able to publish your results. Two approved registries are the International Standard Randomised Controlled Trial Number (ISRCTN) Register and ClinicalTrials.gov. Through the ISRCTN scheme, each trial is given a unique number which enables tracking of the study through publications and reports. There is a fee for registration with ISRCTN, you should request funding for registration in your grant application. ClinicalTrials.gov is free of charge. To register with this scheme, contact ACCORD to create a user account, allowing you access to register trials on the system and release the records for public view once your registration is complete.